Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.

Investors have provided a potentially nine-figure amount to the $561m first close of Daimler-backed FlixMobility's series F round last month.

Qualcomm Ventures-backed bicycle sharing platform Bounce has reportedly raised $120m of a $200m round expected to be mostly funded by existing investors.

JD.com provided $142m for the lift-based advertising screen provider, nine months after it received $302m in funding from Baidu.

The oncology-focused drug developer sourced $77m in the series D round, which was co-led by China Life Healthcare Fund.

The orphan disease drug developer's latest round was led by Novo while Asahi Kasei and Chiesi Ventures also participated, taking its overall funding to $46m.

Exiting investor Mahindra Partners contributed to an Intel Capital-led round that increased the industrial internet-of-things technology developer's total funding to $39m.

SoftBank, Bank Mandiri and Sinar Mas could exit payment software provider Moka in a $100m cash-and-share acquisition by Go-Jek.

Mission Bay Capital has backed a series B round for orphan diseases drug developer Glycomine, which also attracted Novo, Asahi Kasei Pharma and Chiesi.

Sagawa Express, Japan Post and CRE have invested in a $11.7m series B round for the logistics platform developer that was led by Softbank.